{"product_id":"retatrutide","title":"Retatrutide 10-20-30-40mg","description":"\u003cp\u003e\u003cspan\u003eRETATRUTIDE\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eA TRIPLE-RECEPTOR AGONIST UNDER INVESTIGATION IN METABOLIC RESEARCH\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide\u003c\/span\u003e\u003cspan\u003e is an investigational peptide being studied for its activity across multiple metabolic signalling pathways. Research interest centres on its simultaneous agonist activity at \u003c\/span\u003e\u003cspan\u003eGLP-1, GIP and glucagon receptors\u003c\/span\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese receptor systems are involved in areas including appetite signalling, glucose and nutrient metabolism, and energy expenditure. The combination of all three targets distinguishes retatrutide from single- and dual-receptor incretin compounds and has made it an important subject of current metabolic research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide remains \u003c\/span\u003e\u003cspan\u003einvestigational and is not currently an approved medicine\u003c\/span\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWHY RETATRUTIDE IS GENERATING RESEARCH INTEREST\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTriple-Receptor Activity:\u003c\/span\u003e\u003cspan\u003e Retatrutide is being investigated as an agonist of \u003c\/span\u003e\u003cspan\u003eGLP-1, GIP and glucagon receptors\u003c\/span\u003e\u003cspan\u003e, allowing researchers to examine three interconnected metabolic pathways within a single compound.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMetabolic Signalling:\u003c\/span\u003e\u003cspan\u003e Research is examining how combined receptor activity may affect appetite regulation, glucose and lipid metabolism, energy utilisation and energy expenditure.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBodyweight Research:\u003c\/span\u003e\u003cspan\u003e Clinical studies have investigated changes in bodyweight and other metabolic outcomes, making retatrutide a significant area of interest within obesity research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNext-Generation Incretin Research:\u003c\/span\u003e\u003cspan\u003e Retatrutide represents a newer approach beyond traditional GLP-1 receptor agonism and dual-receptor compounds, allowing researchers to investigate the potential effects of broader receptor activation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAREA OF INTEREST\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCurrent research involving retatrutide includes:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cspan\u003eGLP-1 Signalling:\u003c\/span\u003e\u003cspan\u003e Investigation of pathways associated with appetite, satiety and glucose regulation.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eGIP Signalling:\u003c\/span\u003e\u003cspan\u003e Research into insulin-related and broader metabolic signalling.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eGlucagon Signalling:\u003c\/span\u003e\u003cspan\u003e Investigation of pathways associated with energy metabolism and expenditure.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003eMetabolic Research:\u003c\/span\u003e\u003cspan\u003e Clinical investigation into bodyweight, metabolic markers and related physiological outcomes.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRESEARCH STATUS\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide is an \u003c\/span\u003e\u003cspan\u003einvestigational compound undergoing clinical research\u003c\/span\u003e\u003cspan\u003e. Research findings should not be interpreted as establishing safety or effectiveness for unapproved use.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor laboratory\/research purposes only. Not for human consumption or self-administration.\u003c\/span\u003e\u003c\/p\u003e","brand":"My Store 7","offers":[{"title":"10mg","offer_id":60394409492814,"sku":null,"price":34.99,"currency_code":"GBP","in_stock":true},{"title":"20mg","offer_id":60394409525582,"sku":null,"price":49.99,"currency_code":"GBP","in_stock":true},{"title":"30mg","offer_id":60394409558350,"sku":null,"price":59.99,"currency_code":"GBP","in_stock":true},{"title":"40mg","offer_id":60394409591118,"sku":null,"price":74.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1066\/8130\/3374\/files\/F33A69F0-4845-495F-8C9B-FDCE8EED618C.png?v=1786814474","url":"https:\/\/syntrixpeptides.co.uk\/products\/retatrutide","provider":"Syntrix Peptides UK.","version":"1.0","type":"link"}